Best Life Sciences Tech Companies in New Jersey, United States
The 94 best Life Sciences Tech companies in New Jersey, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Certara.
Our analysis of 50 Life Sciences Tech companies
$9.6b in tracked funding; 89% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Tech companies in New Jersey
| # | Company | Last round | Disclosed funding | Employees | Founder | Web popularity | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Adaptive Clinical Systems eClinical technology solutions for data integration, optimization, and interoperability | — | — | 12 | Sina Adibi CEO and President | — | — | — |
| 2 | Advanced Health Media technology and service solutions designed to manage compliant interactions with healthcare professionals and… | — | — | 800 | — | — | — | — |
| 3 | Alanda Software Provider of software solutions of multiple aggregations, tracking and analysis for life sciences industry | — | — | 13 13 → 12 (-8%) | Dean Rossi Founder & President | — | — | 1 launch |
| 4 | Alliance Life Sciences Management & technology consultancy for pharma manufacturers & Life Sciences firms along with solutions for… | — | — | 105 | Alan Crowther CEO | — | — | — |
| 5 | Alpha Clinical Systems Flexible eSource platform modernizing clinical trials, improving data capture and management | — | — | 69 | — | — | — | — |
| 6 | Ancla Developer of solutions for workflow management | — | — | 19 | David Clarke Owner | — | — | — |
| 7 | Astrolabe Provider of cloud-based single-cell data analysis platform for clinical-trail | — | — | — | El Amir Co-Founder & CEO | — | — | — |
| 8 | BEAM Database for clinical trials | — | — | — | Beau Bush Founder & President | — | 82 patents Integrated EV charging systems with phase‑change thermal management for fast, low‑temp operation | — |
Top 12 Life Sciences Tech companies in New Jersey
#1
Series A · Princeton, New Jersey · founded 2025$4Mraised▾
Provider of AI agents for healthcare data analysis and strategy. The agents autonomously identify revenue opportunities and care gaps from claims data. The offering includes insights with specific healthcare providers, accounts, and payers. The agents provide a ready-to-present strategy with a clear business case. The platform offers specialized agents for HCP segmentation, patient journey mapping, and payer strategy.
- Nov 2025Series A$4M
#2
Funding Raised · Montgomery, New Jersey · founded 2005 · 7 employees$17.7Mraised▾
Provider of RFID-based sample tracking systems for biobanks. These systems enable real-time, precise tracking of samples within ultra-low temperature freezers. The offered solutions include systems for mapping freezer box contents without removal, individual vial readers, and software integration with laboratory information management systems (LIMS). This technology improves sample management and reduces the risk of sample loss or misidentification in cold storage environments.
- Mar 2025Grant (prize money)$1.8M
- Feb 2025Grant (prize money)$1.8M
- Sep 2022Grant (prize money)$2.4M
- Sep 2020Grant (prize money)$1.9M
#3
Seed · Jersey City, New Jersey · founded 2022$585Kraised▾
Provider of regulatory affairs search tool for FDA and EMA data. It offers access to pre-approval therapeutics databases, clinical trial information, and regulatory guidelines. The tool facilitates data retrieval from health authorities, enabling users to find information. It supports regulatory affairs professionals in understanding regulatory pathways and compliance requirements.
- Jan 2026Seed$500K
- Nov 2025Seed$85K
#4
Public · Princeton, New Jersey · founded 2008 · 827 employees$340.7Mraised▾
Provider of a platform for in silico drug discovery and consulting services. It has software solutions for molecular modeling and simulation, pharmacokinetic and pharmacodynamic simulation, clinical trial simulators, and scientific informatics. The company provides drug development consulting and medical writing services.
- Sep 2021Grant (prize money)—
- Jul 2021Post IPO$250M
- Jun 2021Grant (prize money)$851.9K
- Nov 2016Grant (prize money)$334.4K
#5
Axtria 🦄Series D · Berkeley Heights, New Jersey · founded 2009 · 749 employees$198.7Mraised▾
Provider of AI-powered data analytics and commercial solutions for life sciences. The company offers data management, engineering, business intelligence, and data visualization services. It also provides marketing, sales, managed care, patient, and forecasting analytics. The company delivers sales force optimization, commercial models, and marketing effectiveness solutions. It offers customer engagement, sales effectiveness, and field force effectiveness services.
- Apr 2021Series D$150M
- Dec 2018Series C$11.5M
- May 2015Series C$20M
- Dec 2014Series B$5.6M
#6
Acquired · Short Hills, New Jersey · founded 2015 · 28 employees$30Mraised▾
Market Access Transformation offers an online platform to find global payers for life sciences projects. The RPR portal enables life sciences companies to connects payers for answering questions, communication and receive compensation. The platform also enables get insight and feedback from the payer network.
- Dec 2020Series C$30M
#7
Series B · Edison, New Jersey · founded 2005$43.4Mraised▾
Digital documentation and data management solutions for providers. The company has developed a software solution that assists with the communication and documentation process. It has features for patient reporting, consent management, and more.
- Mar 2011Series B$7.2M
- Aug 2007Convertible Debt$3.5M
- Feb 2005Series B$8.4M
- Feb 2005Series B$24.3M
#8
Acquired · Jersey City, New Jersey · founded 2012 · 14 employees$17.8Mraised▾
TrialScope provides a cloud-based solution for clinical trial sponsors. The product PharmaCM is a clinical trial disclosure platform to manage to the author, reviewing, editing, approving and publishing the clinical trial application and disclosure data. It offers integrated solutions covering clinical trial registration, transparency, disclosure, and compliance solutions.
- Sep 2018Series A$4M
- Apr 2017Series A$3.6M
- Feb 2015Conventional Debt$2M
- Jun 2014Series A$10.2M
#9
Series A · Morris Plains, New Jersey · founded 1996 · 45 employees$12Mraised▾
Skila offers product launch and KOL management solutions and services for life sciences industry. iAdvocate is its KOL management platform. It also offers solutions for marketing performance management, competitive intelligence, and brand communication. It also provides strategic planning, targeting and segmentation, management planning tools, medical science liaison support, and performance management services. In 2012, Skila merged with Mederi AG a provider of pharmaceutical analytics and stakeholder network intelligence. The combined company offers globally enhanced social analytics and launch management solutions for life science companies under the umbrella brand SkilaMederi.
- Jul 2008Venture Debt—
- Apr 2001Series A$12M
- Apr 2000Series A—
#10
Acquired · Bridgewater, New Jersey · founded 2000 · 240 employees$10.2Mraised▾
marketRx offers sales and marketing solutions to pharmaceutical and biotechnology companies. Offerings include iOptima that provides actionable business intelligence based on available data; iFolio, which evaluates the financial impact of multiple sales force scenarios; iAlign that provides control over information on company's territory alignments; iProfiler, which gathers and reconciles data from field operations team; iForce, a Web-based analytical solution; iTrak that integrates information from various channels and helps sales and marketing decision makers; iResearch, an online market research platform; and iComp, an online tool that provides various reports to the management and the field to review and manage functions in sales operations and management. It also offers consultancy and outsourcing services.
- Oct 2003Series C$10.2M
#11
Acqui-Hired · Princeton, New Jersey · founded 1998 · 350 employees$8.7Mraised▾
CoreLab Partners provides clinical trials, medical image assessment, and cardiac safety solutions and services to the pharmaceutical, biotechnology, and medical device sponsors of clinical trials. Its medical imaging services include central nervous system imaging, oncology imaging, molecular imaging, medical image interpretation and assessment, modalities, regulatory, consulting, dual energy X-ray absorptiometry, and tracking and reporting. In March JLL Partners and Ampersand Capital Partners acquired BioClinica and CoreLab Partners and have combined the two companies under the name BioClinica.
- Jul 2011Series A$8.7M
#12
Acquired · Little Falls, New Jersey · founded 1995$3Mraised▾
Sentrx, (acquired by Telerx in 2013) is a developer and provider of drug safety software solutions and hosting services for the Oracle Argus Safety Suite.The company offers solutions to biopharma organizations for improving safety, adverse event and medical affairs management. Their services range from adverse event data collection and management to safety system setup and hosting and also include primary and secondary research, trend analysis etc. Their proprietary clinical safety solutions include SaPh (a drug safety database management solution with tools and services to manage safety systems), CROPlus (a channel partner solution, offering flexible pharmacovigilance reporting packages) and UniPhi (a single source solution, which integrates all core Sentrx transactions and technology capabilities) which are integrated, customizable and scalable.
- Feb 2009Conventional Debt$3M
- Jun 2006Unattributed—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Tech coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in the United States
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 6,260 United States-affiliated papers.
- Harvard University209
- Cornell University177
- University of Tennessee at Chattanooga140
- Howard Hughes Medical Institute126
- Johns Hopkins University121
- Gene33→164
- Transcription (linguistics)11→79
- Antibody11→62
- Genome6→56
- Mutation7→56
- Gene8→110
- Cell culture3→62
- Gene expression3→62
- Fermentation2→54
- Downregulation and upregulation1→50
- Agriculture19→58
- Antibiotic resistance15→45
- Public health4→31
- Gene6→30
- Production (economics)5→29
Where biotechnology is researched across United States
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing biotechnology patents in the United States
United States biotechnology patent filing is accelerating — 457,918 filings from 8,000 assignees (2016–2025), led by Genentech, UNIV California, Regeneron Pharma; annual filings 36884→44446.
- Genentech18078
- UNIV California17948
- Regeneron Pharma16082
- Amgen10495
- Monsanto Technology9742
- UNIV Pennsylvania8521
- Harvard College7460
- UNIV Texas7378
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.